Background: In March 2007, a Dutch consumer affairs television programme (Radar) questioned the effectiveness of statins in reducing mortality and cardiovascular incidents. We investigated the effects of this television broadcasting on statin prescriptions by GPs in people with and without cardiovascular (co)morbidity and/or diabetes. Methods: Data (2005–07) was used from electronic medical records, collected in a representative sample of 60 general practices in the Netherlands (210 000 registered patients, including 15 000 statin users). Logistic regression and chi-square tests were used to investigate the likelihood of starting and quitting statin prescriptions after the television programme, in comparison with the same period one-year ea...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statins are widely used for the primary and secondary ...
Medical treatments with statins are prescribed to patients with increased risk of cardiovascular eve...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
To quantify how a period of intense media coverage of controversy over the risk:benefit balance of ...
OBJECTIVE: To quantify how a period of intense media coverage of controversy over the risk:benefit ...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTcenter dot More and more countries accept patient reporting ...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot More and more countries accept patient reporting...
BACKGROUND: General Practitioners (GPs) play a central role in controlling an important risk factor ...
Background: Cholesterol-lowering therapy with statins is recommended in established cardiovascular d...
This is the author accepted manuscript. The final version is available from BMJ Publishing Group via...
The introduction of statins has been a breakthrough in the treatment of hypercholesterolaemia. Stati...
Our objective is to estimate the extent to which clinical and non-clinical factors are associated wi...
BACKGROUND: In Belgium, regulations restrict the reimbursement of statins to patients with total ser...
BACKGROUND: In 2014 the UK National Institute for Health and Care Excellence recommended reducing th...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statins are widely used for the primary and secondary ...
Medical treatments with statins are prescribed to patients with increased risk of cardiovascular eve...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...
To quantify how a period of intense media coverage of controversy over the risk:benefit balance of ...
OBJECTIVE: To quantify how a period of intense media coverage of controversy over the risk:benefit ...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTcenter dot More and more countries accept patient reporting ...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot More and more countries accept patient reporting...
BACKGROUND: General Practitioners (GPs) play a central role in controlling an important risk factor ...
Background: Cholesterol-lowering therapy with statins is recommended in established cardiovascular d...
This is the author accepted manuscript. The final version is available from BMJ Publishing Group via...
The introduction of statins has been a breakthrough in the treatment of hypercholesterolaemia. Stati...
Our objective is to estimate the extent to which clinical and non-clinical factors are associated wi...
BACKGROUND: In Belgium, regulations restrict the reimbursement of statins to patients with total ser...
BACKGROUND: In 2014 the UK National Institute for Health and Care Excellence recommended reducing th...
BACKGROUND: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what ex...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statins are widely used for the primary and secondary ...
Medical treatments with statins are prescribed to patients with increased risk of cardiovascular eve...
Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' fo...